0001104659-24-010779.txt : 20240205
0001104659-24-010779.hdr.sgml : 20240205
20240205180130
ACCESSION NUMBER: 0001104659-24-010779
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240201
FILED AS OF DATE: 20240205
DATE AS OF CHANGE: 20240205
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Harris Matthew Scott
CENTRAL INDEX KEY: 0001787762
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32587
FILM NUMBER: 24597203
MAIL ADDRESS:
STREET 1: C/O ALTIMMUNE, INC.
STREET 2: 910 CLOPPER ROAD, SUITE 201S
CITY: GAITHERSBURG
STATE: MD
ZIP: 20878
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Altimmune, Inc.
CENTRAL INDEX KEY: 0001326190
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 202726770
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 910 CLOPPER ROAD
STREET 2: SUITE 201S
CITY: GAITHERSBURG
STATE: MD
ZIP: 20878
BUSINESS PHONE: 2406541450
MAIL ADDRESS:
STREET 1: 910 CLOPPER ROAD
STREET 2: SUITE 201S
CITY: GAITHERSBURG
STATE: MD
ZIP: 20878
FORMER COMPANY:
FORMER CONFORMED NAME: PHARMATHENE, INC
DATE OF NAME CHANGE: 20071016
FORMER COMPANY:
FORMER CONFORMED NAME: HEALTHCARE ACQUISITION CORP
DATE OF NAME CHANGE: 20050505
4
1
tm245213-2_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2024-02-01
0
0001326190
Altimmune, Inc.
ALT
0001787762
Harris Matthew Scott
C/O ALTIMMUNE, INC., 910 CLOPPER ROAD,
SUITE 201S
GAITHERSBURG
MD
20878
0
1
0
0
Chief Medical Officer
0
Common Stock, par value $0.0001
2024-02-01
4
M
0
6166
0
A
49991
D
Common Stock, par value $0.0001
2024-02-01
4
F
0
1801
9.88
D
48190
D
Common Stock, par value $0.0001
2024-02-02
4
M
0
7775
0
A
55965
D
Common Stock, par value $0.0001
2024-02-02
4
F
0
2332
9.32
D
53633
D
Restricted Stock Units
2024-02-01
4
M
0
6166
0.00
D
Common Stock, par value $0.0001
6166
6166
D
Restricted Stock Units
2024-02-02
4
M
0
7775
0.00
D
Common Stock, par value $0.0001
7775
15550
D
Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested.
Vesting transaction: Shares surrendered to the Issuer solely to cover taxes associated with vesting of RSUs.
The RSUs become vested in substantially equal annual installments over the 4 years following February 1, 2021, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date.
The RSUs become vested in substantially equal annual installments over the 4 years following February 2, 2022, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date.
/s/ Richard I. Eisenstadt, as Attorney-in-Fact
2024-02-05